T-group (topology)
1126.1.1 Mitochondrial complex I, MWFE subunit
Ligands and drugs
305
Member domains
224
with ligand contacts (≤ 4 Å)
73.4% of members
110
with DrugDomain annotations
36.1% of members
99
with a DrugBank compound
32.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 1126.1.1 belongs to X-group 1126 Mitochondrial complex I, MWFE subunit, which has 9 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03429 | CDL | Tetrastearoyl cardiolipin | 76 |
| DB04327 | PEE | Phosphatidylethanolamine | 61 |
| DB02777 | PLC | Diundecyl Phosphatidyl Choline | 3 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CDL | CARDIOLIPIN | 183 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 75 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 63 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 47 |
| PLX | (9R,11S)-9-({[(1S)-1-HYDROXYHEXADECYL]OXY}METHYL)-2,2-DIMETHYL-5,7,10-TRIOXA-2LAMBDA~5~-AZA-6LAMBDA~5~-PHOSPHAOCTACOSANE-6,6,11-TRIOL | 9 |
| SF4 | IRON/SULFUR CLUSTER | 4 |
| Q7G | 2-{[(4-O-alpha-D-glucopyranosyl-alpha-D-glucopyranosyl)oxy]methyl}-4-{[(3beta,9beta,14beta,17beta,25R)-spirost-5-en-3-yl]oxy}butyl 4-O-alpha-D-glucopyranosyl-alpha-D-glucopyranoside | 2 |
| UQ5 | 2,3-DIMETHOXY-5-METHYL-6-(3,11,15,19-TETRAMETHYL-EICOSA-2,6,10,14,18-PENTAENYL)-[1,4]BENZOQUINONE | 2 |
| 6F6 | (4S,7R)-4-hydroxy-N,N,N-trimethyl-7-(octadecanoyloxy)-4,10-dioxo-3,5,9-trioxa-4lambda~5~-phosphaheptacosan-1-aminium | 1 |
| PLC | DIUNDECYL PHOSPHATIDYL CHOLINE | 1 |